Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies.

Aspatwar A, Winum JY, Carta F, Supuran CT, Hammaren M, Parikka M, Parkkila S

Open source

DOI
10.3390/molecules23112911
Published
2018 Nov 8
Container
Molecules (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/molecules23112911,
  title = {Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies.},
  author = {Aspatwar A and Winum JY and Carta F and Supuran CT and Hammaren M and Parikka M and Parkkila S},
  year = {2018},
  journal = {Molecules (Basel, Switzerland)},
  doi = {10.3390/molecules23112911},
  url = {https://doi.org/10.3390/molecules23112911}
}

RIS

TY  - JOUR
TI  - Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies.
AU  - Aspatwar A
AU  - Winum JY
AU  - Carta F
AU  - Supuran CT
AU  - Hammaren M
AU  - Parikka M
AU  - Parkkila S
PY  - 2018
JO  - Molecules (Basel, Switzerland)
DO  - 10.3390/molecules23112911
UR  - https://doi.org/10.3390/molecules23112911
ER  - 

APA

A, A., JY, W., F, C., CT, S., M, H., M, P., & S, P. (2018). Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies.. Molecules (Basel, Switzerland). https://doi.org/10.3390/molecules23112911

Source records